Learn about Laboratory Considerations when Developing Multiple Myeloma Trials

Presented by

Dr. Domenica Gandini, ICON

About this talk

Join ICON’s experts Dr. Marc Golightly, PhD and Domenica Gandini as they speak about considerations when developing Multiple Myeloma trials. With the growing number of therapeutics being developed for Multiple Myeloma, the need for laboratory expertise in Multiple Myeloma clinical trials is paramount to proper evaluation/assessment of patient responses. A knowledge of the pitfalls, how to avoid them, and newer diagnostic testing will all contribute to the success of the study design and analysis of responses. Key Insights that will be covered: Basic review of Multiple Myeloma Importance of an experienced dedicated group of myeloma laboratory technologists and multi-level review of data Centralization of laboratory services and minimizing variation Understanding and minimizing the pitfalls in laboratory testing of Myeloma patients New technologies available for improving the assessment monoclonal antibody levels Speakers: Dr. Marc Golightly, Stony Brook University; Dr. Domenica Gandini, Director, ICON

Related topics:

More from this channel

Upcoming talks (0)
On-demand talks (32)
Subscribers (507)
BioPharma companies and Medical Devices manufacturers face growing operational, regulatory and economic challenges when it comes to developing their drug or device. ICON provides analysis and key insights on these challenges, with practical advice and recommendations.